Asymptomatic Mansonelliasis: Treatment Options Explained
At a Glance
Treatment for asymptomatic Mansonelliasis depends on the specific parasite species. While infections can clear on their own over several years, doctors often recommend active treatment with ivermectin or doxycycline to prevent future symptoms and subtle immune system changes.
In this answer
3 sections
If you have tested positive for Mansonella after traveling but feel completely healthy, you may not need immediate treatment, though many infectious disease experts still recommend it [1][2]. Because Mansonella infections are often mild and there are no standardized international treatment guidelines, the choice between active treatment and “watchful waiting” (monitoring) depends on the exact species you have, your overall health, and the potential risks of the medications [1][3].
Understanding Asymptomatic Mansonelliasis
Mansonelliasis is caused by filarial roundworms, most commonly Mansonella perstans and Mansonella ozzardi (and occasionally Mansonella streptocerca) [4]. People acquire the parasite through the bites of infected midges or blackflies in parts of Africa, South America, and the Caribbean. It is very common for travelers to discover the infection incidentally—such as during routine blood work—because these parasites frequently cause no symptoms at all [5][4].
Can it go away on its own?
Filarial worms cannot multiply inside the human body; they require the insect vector to complete their lifecycle. Because you are no longer traveling in an area where infected insects are biting you, the number of adult worms in your body will not increase. The worms will eventually die of old age, meaning the infection can clear on its own over time. However, adult worms can live in your body for several years [5][6].
While historically considered a harmless infection, recent research suggests that even silent Mansonella infections can cause subtle, long-term changes to how your body responds to other challenges [4][7]. This is sometimes referred to medically as “immune modulation.” It does not mean you will develop an autoimmune disease; rather, the parasite tries to protect itself by temporarily dampening your immune response, which might slightly reduce your body’s ability to fight off other infections or lower the effectiveness of vaccines over time [6][8].
Monitoring vs. Active Treatment
Because there are no official guidelines from organizations like the Centers for Disease Control and Prevention (CDC) or the World Health Organization (WHO) for asymptomatic cases, your doctor will weigh the pros and cons of treatment with you [1][3][9].
What “Watchful Waiting” Looks Like
If you and your doctor choose monitoring, it usually doesn’t mean enduring frequent, invasive tests. You will primarily watch for the development of subtle symptoms—like unexplained itching, joint pain, or fatigue—which would prompt a switch to active treatment. Your doctor might also recommend periodic blood tests (e.g., once a year) to check if your body is slowly clearing the infection [1][9].
- Mild impact: Without symptoms, the immediate threat to your health is extremely low [5].
- Avoiding medication side effects: Standard anti-parasitic drugs and long courses of antibiotics can cause side effects like stomach upset. If your infection isn’t causing harm, your doctor may prefer to avoid unnecessary medications [5][10].
Reasons a Doctor Might Recommend Treatment
- Long-term persistence: Because the worms can live in the body for years, treating them prevents the potential dampening of your immune system [5][6].
- Preventing future symptoms: Eradicating the infection early ensures you never develop symptoms later on.
- Peace of mind: Many specialists prefer to cure any diagnosed parasitic infection, regardless of symptoms, to prevent any unknown long-term complications [2][11].
Treatment Options by Species
If you decide to pursue treatment, the approach depends heavily on the specific Mansonella species [1][2]. Your doctor can usually determine which species you have by examining your blood under a microscope to look at the shape of the microscopic worms, or by sending your blood for specialized DNA testing (PCR) [12][13].
- Mansonella ozzardi: This species is generally highly susceptible to a single dose of ivermectin, an anti-parasitic medication [14].
- Mansonella perstans: This species is notoriously difficult to treat because standard anti-parasitics (like albendazole or mebendazole) often fail to clear the infection [15][1]. However, M. perstans relies on a symbiotic bacteria called Wolbachia to survive and reproduce [16][17]. By taking doxycycline (an antibiotic) for an extended period (often 4 to 6 weeks), the Wolbachia bacteria are destroyed, which eventually interrupts the worms’ fertility and reduces the infection [17][18]. Keep in mind that a 4-to-6-week course of doxycycline requires a serious commitment and can cause side effects like increased sun sensitivity and gastrointestinal upset [10].
A Crucial Safety Step: Checking for Co-infections
Before taking any anti-parasitic medication like ivermectin or diethylcarbamazine (DEC), your doctor must ensure you were not also exposed to another parasite called Loa loa during your travels [19]. This usually involves a specialized “daytime blood smear,” because Loa loa is most active in the bloodstream during the middle of the day. Treating an asymptomatic Mansonella infection in someone who unknowingly has a high burden of Loa loa can trigger rapid parasite death, leading to severe, potentially life-threatening neurological reactions [19][20][21].
Common questions in this guide
Do I need treatment for a Mansonella infection if I have no symptoms?
Can Mansonelliasis go away on its own?
How is Mansonella ozzardi treated?
Why is a long course of doxycycline used to treat Mansonella perstans?
Why do I need a special blood test before starting Mansonelliasis treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given the specific regions I traveled to, do you recommend treating my asymptomatic infection or actively monitoring it?
- 2.Which specific species of Mansonella did my bloodwork show, and how does that impact my treatment options?
- 3.Will you be ordering a daytime blood smear to check for Loa loa co-infection before we consider any medications?
- 4.If we choose to monitor the infection, what specific symptoms or changes should I watch out for?
- 5.If I need a long course of doxycycline, what are the most common side effects I should anticipate?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (21)
- 1
Mansonellosis: current perspectives.
Ta-Tang TH, Crainey JL, Post RJ, et al.
Research and reports in tropical medicine 2018; (9()):9-24 doi:10.2147/RRTM.S125750.
PMID: 30050351 - 2
The search for better treatment strategies for mansonellosis: an expert perspective.
Ferreira MU, Crainey JL, Gobbi FG
Expert opinion on pharmacotherapy 2023; (24(15)):1685-1692 doi:10.1080/14656566.2023.2240235.
PMID: 37477269 - 3
New treatment strategies for mansonellosis: an expert overview.
Suwa UF, Montefusco ELB, de Araújo CPM, et al.
Expert review of anti-infective therapy 2026; doi:10.1080/14787210.2026.2653752.
PMID: 41910088 - 4
An Overview of the Management of Mansonellosis.
Ta-Tang TH, Luz SLB, Crainey JL, Rubio JM
Research and reports in tropical medicine 2021; (12()):93-105 doi:10.2147/RRTM.S274684.
PMID: 34079424 - 5
A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe.
Tamarozzi F, Rodari P, Salas-Coronas J, et al.
Journal of travel medicine 2022; (29(7)) doi:10.1093/jtm/taac048.
PMID: 35417002 - 6
Mansonella perstans - the forgotten filaria.
Ritter M, Hsu HY, Lenz B, et al.
Trends in parasitology 2025; (41(10)):909-921 doi:10.1016/j.pt.2025.08.003.
PMID: 40908246 - 7
Mansonella ozzardi: a neglected New World filarial nematode.
Lima NF, Veggiani Aybar CA, Dantur Juri MJ, Ferreira MU
Pathogens and global health 2016; (110(3)):97-107 doi:10.1080/20477724.2016.1190544.
PMID: 27376501 - 8
Inflammatory and regulatory CCL and CXCL chemokine and cytokine cellular responses in patients with patent Mansonella perstans filariasis.
Wangala B, Gantin RG, Voßberg PS, et al.
Clinical and experimental immunology 2019; (196(1)):111-122 doi:10.1111/cei.13251.
PMID: 30561772 - 9
Mansonellosis, the most neglected human filariasis.
Mediannikov O, Ranque S
New microbes and new infections 2018; (26()):S19-S22 doi:10.1016/j.nmni.2018.08.016.
PMID: 30402239 - 10
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
Grant JS, Stafylis C, Celum C, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(6)):1247-1253 doi:10.1093/cid/ciz866.
PMID: 31504345 - 11
Filarial disease in the Brazilian Amazon and emerging opportunities for treatment and control.
Portela CS, Mendes de Araújo CP, Moura Sousa P, et al.
Current research in parasitology & vector-borne diseases 2024; (5()):100168 doi:10.1016/j.crpvbd.2023.100168.
PMID: 38283060 - 12
Sensitivity of diagnostic methods for Mansonella ozzardi microfilariae detection in the Brazilian Amazon Region.
Medeiros JF, Fontes G, Nascimento VLD, et al.
Memorias do Instituto Oswaldo Cruz 2018; (113(3)):173-177 doi:10.1590/0074-02760170321.
PMID: 29412356 - 13
In Silico Identification of Novel Biomarkers and Development of New Rapid Diagnostic Tests for the Filarial Parasites Mansonella perstans and Mansonella ozzardi.
Poole CB, Sinha A, Ettwiller L, et al.
Scientific reports 2019; (9(1)):10275 doi:10.1038/s41598-019-46550-9.
PMID: 31311985 - 14
Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of Mansonella ozzardi infection in the Brazilian Amazon.
de Almeida Basano S, de Souza Almeida Aranha Camargo J, Fontes G, et al.
The American journal of tropical medicine and hygiene 2018; (98(3)):786-790 doi:10.4269/ajtmh.17-0698.
PMID: 29313486 - 15
Pulmonary localization of Mansonella perstans in a 16 months-old male patient in a tertiary care hospital in Bukavu, Democratic Republic of Congo.
Kabego L, Kasengi JB, Mirindi P, et al.
Germs 2016; (6(4)):151-154 doi:10.11599/germs.2016.1101.
PMID: 28053918 - 16
Wolbachia bacteria in Mansonella perstans isolates from patients infected in different geographical areas: a pilot study from the ESCMID Study Group for Clinical Parasitology.
Pomari E, Voronin D, Alvarez-Martinez MJ, et al.
Parasites & vectors 2025; (18(1)):97 doi:10.1186/s13071-025-06723-0.
PMID: 40065479 - 17
The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana.
Batsa Debrah L, Phillips RO, Pfarr K, et al.
The American journal of tropical medicine and hygiene 2019; (101(1)):84-92 doi:10.4269/ajtmh.18-0491.
PMID: 31162017 - 18
Successful treatment of 2 imported cases of Mansonella perstans infection.
Asgeirsson H, Harling A, Botero-Kleiven S
PLoS neglected tropical diseases 2017; (11(5)):e0005452 doi:10.1371/journal.pntd.0005452.
PMID: 28542192 - 19
Activity of antifilarial drugs on microfilaremia in the treatment of loiasis: a systematic review.
Michelitsch P, Matthies L, Nordmann T, et al.
Parasites & vectors 2025; doi:10.1186/s13071-025-07189-w.
PMID: 41372923 - 20
Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.
Saito M, Armstrong M, Boadi S, et al.
The American journal of tropical medicine and hygiene 2015; (93(3)):607-11 doi:10.4269/ajtmh.15-0214.
PMID: 26101271 - 21
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.
Legrand F, Herrick J, Makiya M, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(7)):e1624-e1631 doi:10.1093/cid/ciaa1365.
PMID: 32910141
This page provides general information about treatment guidelines for asymptomatic Mansonelliasis. Always consult an infectious disease or travel medicine specialist to determine the safest and most appropriate care plan for your specific diagnosis.
Get notified when new evidence is published on Filariasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.